药物对比
Saxagliptin vs Lixisenatide
比较Saxagliptin与Lixisenatide治疗2型糖尿病：口服DPP-4抑制剂 vs 每日注射GLP-1。疗效、体重、与胰岛素联合使用、副作用。
此页面暂无可用的对比维度。
临床背景
Patients with type 2 diabetes considering oral DPP-4 inhibitors versus injectable GLP-1 agonists, often alongside basal insulin.
结论
Lixisenatide typically offers greater post-meal control and extras while Saxagliptin provides oral ease, so neither is universally superior.
全部药物对比